Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dasatinib and Paclitaxel
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Bristol-Myers Squibb